Delivery Order SPE2DB22D1106-SPE2DB24FEXN8
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical services company Amerisourcebergen Corporation. The $2,994.80 contract is for the delivery of the prescription medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of...
- The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,329.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This order, which has a completion date of June 12, 2024, is for the supply of the prescription drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,131.02 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D2007|SPE2DB24FJ1MD) worth $1,257.04 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $5,828.89 and a period of performance through April 4, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. government awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $1,097.08. This firm fixed price order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, supporting medical treatment programs and facilities operated by the Department of Defense. The order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the publicly traded Amerisourcebergen Corporation, to provide a specialty pharmaceutical product called WEGOVY 1 MG/0.5 ML PEN 0.5ML. The order, valued at $3,291.24, has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEXN8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $6,533.36, to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. No set-aside was used for this specific Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain network to fulfill these types of government contracts for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 6/17/24 |